Lansoprazole Capsule, Delayed Release
Product Images NDC 50090-6154

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 50090-6154). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1.jpg (Figure 1)

A line graph showing the mean severity of day heartburn over time for evaluable patients in a study. The x-axis represents days from the start of treatment, ranging from -5 to 60, and the y-axis represents the mean severity of day heartburn on a scale from 0 (none) to 3 (severe). The graph compares placebo, Lansoprazole 15 mg once daily, and Lansoprazole 30 mg once daily groups, illustrating a decrease in heartburn severity over time for both Lansoprazole doses compared to placebo.*

FDA Label Image

Figure-2.jpg (Figure 2)

A line graph showing the mean severity of night heartburn over time by study day for evaluable patients. The y-axis represents the mean severity of night heartburn ranging from 0 (none) to 3 (severe). The x-axis represents days from the start of treatment, spanning from day -5 to day 60. Three lines compare placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD, illustrating a decrease in heartburn severity over the treatment period, with Lansoprazole 30 mg showing the greatest reduction.*

FDA Label Image

Formula-structure.jpg (Image 01)

Chemical structure of Lansoprazole, showing the molecular arrangement including benzimidazole and pyridine rings with associated functional groups.*

FDA Label Image

Label Image (Lbl500906154)

Label for Lansoprazole delayed-release capsules, 30 mg strength, in a package containing 30 capsules. The product is labeled by A-S Medication Solutions. The label includes storage instructions to keep at 68 to 77 degrees Fahrenheit, the NDC 50090-6154-0, and specifies that each delayed-release capsule contains 30 mg of lansoprazole.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.